ATE258986T1 - Sekretorischer rekombinanter bcg impfstoff gegen aids - Google Patents

Sekretorischer rekombinanter bcg impfstoff gegen aids

Info

Publication number: ATE258986T1
Authority: AT; Austria
Prior art keywords: antigen; fused protein; alpha; bcg; vaccine against
Prior art date: 1994-07-29

Application number

AT95926523T

Other languages

English (en)

Inventor

Kazuhiro Matsuo

Yoshitomo Chujo

Akihiro Yamazaki

Mitsuo Honda

Shudo Yamazaki

Hiromichi Tasaka

Original Assignee

Ajinomoto Kk

Agency Nat Inst Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-29

Filing date

1995-07-31

Publication date

2004-02-15

1995-07-31 Application filed by Ajinomoto Kk, Agency Nat Inst Health filed Critical Ajinomoto Kk

2004-02-15 Application granted granted Critical

2004-02-15 Publication of ATE258986T1 publication Critical patent/ATE258986T1/de

Links

208000030507 AIDS Diseases 0.000 title 1
229960000190 bacillus calmette–guérin vaccine Drugs 0.000 title 1
230000003248 secreting effect Effects 0.000 title 1
239000000427 antigen Substances 0.000 abstract 5
108090000623 proteins and genes Proteins 0.000 abstract 5
102000004169 proteins and genes Human genes 0.000 abstract 5
241001465754 Metazoa Species 0.000 abstract 3
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
229960005486 vaccine Drugs 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
241001467552 Mycobacterium bovis BCG Species 0.000 abstract 1
108010076504 Protein Sorting Signals Proteins 0.000 abstract 1
210000003719 b-lymphocyte Anatomy 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
- C12N15/03—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Public Health (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT95926523T 1994-07-29 1995-07-31 Sekretorischer rekombinanter bcg impfstoff gegen aids ATE258986T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP17846294		1994-07-29
PCT/JP1995/001515 WO1996004009A1 (en)	1994-07-29	1995-07-31	Anti-aids secretory recombinant bcg vaccine

Publications (1)

Publication Number	Publication Date
ATE258986T1 true ATE258986T1 (de)	2004-02-15

Family

ID=16048947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95926523T ATE258986T1 (de)	1994-07-29	1995-07-31	Sekretorischer rekombinanter bcg impfstoff gegen aids

Country Status (6)

Country	Link
EP (1)	EP0745386B1 (de)
KR (1)	KR100217809B1 (de)
CN (1)	CN1136280A (de)
AT (1)	ATE258986T1 (de)
DE (1)	DE69532524D1 (de)
WO (1)	WO1996004009A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0917866A1 (de)	1997-11-12	1999-05-26	The Procter & Gamble Company	Damenbinde mit einem gestuften Klebestreifen
JP2002114708A (ja) *	2000-10-06	2002-04-16	Puraimyuun Corporation:Kk	Ｄｎａワチンに対するアジュバント剤
US7625572B2 (en) *	2004-12-01	2009-12-01	Aeras Global Tb Vaccine Foundation	Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria
CN101456905B (zh) *	2008-12-05	2013-01-16	中国科学院海洋研究所	一种细菌五型分泌蛋白及其构建方法和应用
CN103497926B (zh) *	2013-10-21	2016-02-10	深圳大学	表达分泌人类p53蛋白的重组BCG活菌菌株、活菌疫苗及其构建方法和应用
CN108823232A (zh) *	2018-04-20	2018-11-16	中国科学院广州生物医药与健康研究院	一种艾滋病疫苗及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69027956T2 (de) *	1989-05-31	1997-03-06	Ajinomoto Kk	Sekretorische Expressionsvektoren für Mycobakterien sowie Transformanten
JP2903414B2 (ja) *	1989-05-31	1999-06-07	味の素株式会社	抗酸菌分泌発現ベクター及び抗酸菌

1995
- 1995-07-31 EP EP95926523A patent/EP0745386B1/de not_active Expired - Lifetime
- 1995-07-31 DE DE69532524T patent/DE69532524D1/de not_active Expired - Lifetime
- 1995-07-31 KR KR1019960701625A patent/KR100217809B1/ko not_active Expired - Fee Related
- 1995-07-31 AT AT95926523T patent/ATE258986T1/de not_active IP Right Cessation
- 1995-07-31 CN CN95190959A patent/CN1136280A/zh active Pending
- 1995-07-31 WO PCT/JP1995/001515 patent/WO1996004009A1/ja not_active Ceased

Also Published As

Publication number	Publication date
KR100217809B1 (ko)	1999-09-01
EP0745386B1 (de)	2004-02-04
CN1136280A (zh)	1996-11-20
DE69532524D1 (de)	2004-03-11
WO1996004009A1 (en)	1996-02-15
KR960704570A (ko)	1996-10-09
EP0745386A1 (de)	1996-12-04
EP0745386A4 (de)	1999-07-14

Legal Events

Date	Code	Title	Description
2004-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE3775458D1 (de)	1992-02-06	Vermehrung der antigenimmunogenizitaet.
PT88329A (pt)	1989-06-30	Bacterias nao virulentas contra infeccoes estreptococicas
DE69838383D1 (de)	2007-10-18	Kulturmedium mit sojabohnenextrakt als aminosäuren-quelle und ohne proteinkomplexe tierischen ursprungs
ATE123065T1 (de)	1995-06-15	Proteine und deren herstellung.
AP2001002199A0 (en)	2001-09-30	Novel streptococcus antigens
DE60117164D1 (de)	2006-04-20	Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
ATE132195T1 (de)	1996-01-15	Rekombinant-mykobakterielle impfstoffe
CA2079463A1 (en)	1991-10-01	Live vaccines
ES531986A0 (es)	1985-09-01	Un metodo de producir una forma geneticamente estable de vidrio cholerae
WO2001096368A3 (en)	2002-05-02	Use of coiled-coil structural scaffold to generate structure-specific peptides
NO872988D0 (no)	1987-07-17	Pattedyr-interleukin-4.
ATE321859T1 (de)	2006-04-15	B2microglobulin fusionsproteine und varianten mit hoher affinität
ES2196155T3 (es)	2003-12-16	Pprocedimientos para inducir la produccion de anticuerpos contra las bacterias de la familia cs4-cfa/1 de e. coli.
ATE258986T1 (de)	2004-02-15	Sekretorischer rekombinanter bcg impfstoff gegen aids
DE69737413D1 (en)	2007-04-12	Bakterioferritin aus helicobacter pylori
CA2089753A1 (en)	1992-02-23	Interleukin-2-leukotoxin gene fusions and uses therefor
ATE302016T1 (de)	2005-09-15	Peptide, verwendet als träger in immunogenen konstrukten, die in der entwicklung synthetischer impfstoffe geeignet sind
DE3585578D1 (de)	1992-04-16	Hepatitisoberflaechenantigenpartikelvakzin.
ATE107516T1 (de)	1994-07-15	Pasteurella-impfstoff.
ES2080024A1 (es)	1996-01-16	Vacuna subunitaria recombinante contra la enfermedad hemorragica virica de los conejos.
DK145988D0 (da)	1988-03-17	Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
DE60033823D1 (de)	2007-04-19	Rekombinante mikroorganismen
EP0293201A3 (de)	1990-02-28	Methode zur Impfung gegen Hepatitis-B-Virus
Poff-Reichow	1999	Development of Brucella abortus RB51 as a Vaccine to Protect Against Brucellosis and Anthrax
DE68926294D1 (de)	1996-05-23	Antigen gegen diabetes